https://www.selleckchem.com/pr....oducts/smoothened-ag
. To investigate the association of potential cardiovascular disease (CVD) biomarkers in patients with type 2 diabetes. We enrolled 120 participants (aged 61.5-69.5 years) with type 2 diabetes and 60 (aged 62.5-73.5 years) with normal glucose tolerance in the discovery group from the original Da Qing Diabetes Study. Their diabetes status was confirmed in 1986; then, the participants were followed over 23 years to collect CVD outcome data. Untargeted and targeted metabolomics analyses based on ultra-high-performance li
Like
Comment
Share
